Holen Sie sich die Stockscreener-App
220.78
0.11%
0.2371
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ORCL?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$220.54
Offen:
$220.03
24-Stunden-Volumen:
10.56M
Relative Volume:
0.39
Marktkapitalisierung:
$629.37B
Einnahmen:
$59.02B
Nettoeinkommen (Verlust:
$12.63B
KGV:
51.11
EPS:
4.3198
Netto-Cashflow:
$-5.88B
1W Leistung:
+9.79%
1M Leistung:
-7.72%
6M Leistung:
+24.63%
1J Leistung:
+15.93%
1-Tages-Spanne:
$218.28
$222.11
1-Wochen-Bereich:
$199.40
$224.75
52-Wochen-Spanne:
$118.86
$345.72
Oracle Corp Stock (ORCL) Company Profile
Firmenname
Oracle Corp
Sektor
Branche
Telefon
(737) 867-1000
Adresse
2300 ORACLE WAY, AUSTIN, CA
Vergleichen Sie ORCL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORCL
Oracle Corp
|
220.77 | 628.71B | 59.02B | 12.63B | -5.88B | 4.3198 |
|
MSFT
Microsoft Corporation
|
490.62 | 3.65T | 293.81B | 104.91B | 78.02B | 14.06 |
|
PLTR
Palantir Technologies Inc
|
180.94 | 432.57B | 3.90B | 1.10B | 1.79B | 0.4275 |
|
CRWD
Crowdstrike Holdings Inc
|
519.54 | 129.88B | 4.57B | -315.36M | 1.10B | -1.2634 |
|
SNPS
Synopsys Inc
|
463.85 | 88.76B | 6.43B | 1.15B | 1.30B | 12.77 |
Oracle Corp Stock (ORCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-03 | Eingeleitet | Wells Fargo | Overweight |
| 2025-11-10 | Herabstufung | Erste Group | Buy → Hold |
| 2025-10-13 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-10-09 | Eingeleitet | Robert W. Baird | Outperform |
| 2025-09-25 | Eingeleitet | Rothschild & Co Redburn | Sell |
| 2025-09-10 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-09-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-09-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-09-09 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-07-17 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-07-10 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-07-02 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-06-30 | Hochstufung | Stifel | Hold → Buy |
| 2025-06-18 | Bestätigt | Guggenheim | Buy |
| 2025-06-13 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2025-06-09 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-04-23 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-03-19 | Eingeleitet | Stephens | Equal-Weight |
| 2025-03-11 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-03-03 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
| 2025-01-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-20 | Herabstufung | Monness Crespi & Hardt | Neutral → Sell |
| 2024-10-23 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2024-09-16 | Hochstufung | Melius | Hold → Buy |
| 2024-09-10 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-09-10 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2024-06-17 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-04-18 | Eingeleitet | Oppenheimer | Perform |
| 2024-03-21 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-03-14 | Hochstufung | Argus | Hold → Buy |
| 2024-03-12 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-03-12 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-12-12 | Bestätigt | BMO Capital Markets | Market Perform |
| 2023-11-13 | Hochstufung | Edward Jones | Hold → Buy |
| 2023-10-09 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-15 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-14 | Hochstufung | DZ Bank | Hold → Buy |
| 2023-09-13 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-09-12 | Herabstufung | Monness Crespi & Hardt | Buy → Neutral |
| 2023-09-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-08-29 | Hochstufung | UBS | Neutral → Buy |
| 2023-06-13 | Hochstufung | Goldman | Sell → Neutral |
| 2023-06-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-04-20 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2023-03-10 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-01-18 | Eingeleitet | DA Davidson | Neutral |
| 2023-01-11 | Eingeleitet | Mizuho | Buy |
| 2023-01-09 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-01-05 | Hochstufung | Jefferies | Hold → Buy |
| 2022-10-21 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-10-20 | Hochstufung | Piper Sandler | Underweight → Neutral |
| 2022-09-14 | Eingeleitet | Berenberg | Hold |
| 2022-08-12 | Eingeleitet | Guggenheim | Buy |
| 2022-06-29 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2022-06-27 | Fortgesetzt | Goldman | Sell |
| 2022-06-14 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2022-04-01 | Eingeleitet | Daiwa Securities | Neutral |
| 2022-03-29 | Herabstufung | Exane BNP Paribas | Neutral → Underperform |
| 2022-03-11 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2022-03-11 | Hochstufung | Societe Generale | Hold → Buy |
| 2021-12-21 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-12-15 | Hochstufung | DZ Bank | Sell → Hold |
| 2021-12-10 | Bestätigt | BMO Capital Markets | Market Perform |
| 2021-12-10 | Bestätigt | Barclays | Equal Weight |
| 2021-12-10 | Bestätigt | Citigroup | Neutral |
| 2021-12-10 | Bestätigt | Cowen | Outperform |
| 2021-12-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-12-10 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-12-10 | Bestätigt | Piper Sandler | Neutral |
| 2021-12-10 | Bestätigt | Societe Generale | Hold |
| 2021-12-10 | Bestätigt | Stifel | Hold |
| 2021-12-10 | Bestätigt | UBS | Neutral |
| 2021-12-10 | Bestätigt | Wolfe Research | Peer Perform |
| 2021-11-16 | Eingeleitet | Credit Suisse | Outperform |
| 2021-11-02 | Eingeleitet | Deutsche Bank | Hold |
| 2021-09-14 | Bestätigt | BMO Capital Markets | Market Perform |
| 2021-09-14 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-08-10 | Herabstufung | DZ Bank | Hold → Sell |
| 2021-05-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-04-23 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-04-21 | Herabstufung | DZ Bank | Buy → Hold |
| 2021-04-01 | Fortgesetzt | Wedbush | Neutral |
| 2021-03-22 | Fortgesetzt | Evercore ISI | In-line |
| 2021-03-16 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-11 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-03-11 | Herabstufung | Societe Generale | Buy → Hold |
| 2021-03-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-03-03 | Fortgesetzt | Citigroup | Neutral |
| 2021-01-22 | Eingeleitet | Goldman | Sell |
| 2020-12-18 | Hochstufung | Monness Crespi & Hardt | Neutral → Buy |
| 2020-12-16 | Fortgesetzt | BofA Securities | Neutral |
| 2020-12-08 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-11-24 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Fortgesetzt | UBS | Neutral |
| 2020-09-21 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-09-11 | Bestätigt | BMO Capital Markets | Market Perform |
| 2020-09-11 | Bestätigt | Barclays | Equal Weight |
| 2020-09-11 | Bestätigt | Credit Suisse | Outperform |
| 2020-09-11 | Bestätigt | Goldman | Buy |
| 2020-09-11 | Bestätigt | Jefferies | Hold |
| 2020-09-11 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2020-09-11 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-09-11 | Bestätigt | Stifel | Hold |
| 2020-09-11 | Bestätigt | Wells Fargo | Overweight |
| 2020-06-19 | Herabstufung | Argus | Buy → Hold |
| 2020-06-01 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2020-03-31 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-03-13 | Bestätigt | BMO Capital Markets | Market Perform |
Alle ansehen
Oracle Corp Aktie (ORCL) Neueste Nachrichten
From Oracle to Starlink: Lebanon’s security sovereignty in the wind - Tehran Times
Oracle's OpenAI reliance faces scrutiny as debt-fueled AI buildout raises worries - Yahoo Finance
Oracle Stock in Spotlight -- Top Analyst See 65% Upside Ahead of Q2 Earnings - Yahoo Finance
Looking Into Oracle Corp's Recent Short Interest - Benzinga
RBC Capital keeps $310 price target for Oracle (ORCL) ahead of Q2 FY2026 earnings - MSN
GSI, Inc. Named a High Performer in the G2 Grid® Report for Oracle Consulting Services | Winter 2026 - GlobeNewswire
Bet On Oracle Or Synopsys? - Forbes
Stocks Waver as Traders Stay on Sidelines Ahead of Fed, Oracle - Bloomberg.com
Oracle (ORCL) Stock: Can Wednesday’s Earnings Reverse a 37% Three-Month Slide? - parameter.io
Oracle Q2 earnings on deck: What to expect - MSN
Oracle (ORCL) Stock: Climbs Almost 2% on OpenAI Partnership and Cloud Momentum - CoinCentral
ORACLE CORP : JP Morgan is Neutral - marketscreener.com
Oracle's AI Cloud Surge: From Summer Glory to a Dip Worth Buying - Yahoo Finance Singapore
Oracle earnings on deck: 3 things this analyst is watching - Yahoo Finance
Oracle is the canary in the coal mine for Big Tech’s debt-fueled AI spending spree - MarketWatch
Oracle Earnings: What To Look For From ORCL - The Globe and Mail
MolecuLightDX® Now Available on Oracle Healthcare Marketplace - PR Newswire
Here's How Much Traders Expect Oracle Stock to Move After Earnings Wednesday - Investopedia
MavenWire achieves Oracle Partner Network Specialized status for Oracle Transportation Management (OTM) solution - Supply & Demand Chain Executive
Oracle Stock: Dip Or Trap? - Forbes
Cloud, debt and AI promises: the Oracle checklist before earnings - home.saxo
Adobe, Oracle, Broadcom Earnings Preview: Sales and AI Demand in Spotlight - Investing.com
Oracle Stock 2025: Earnings Beat, Cloud Momentum and What Investors Should Know - vocal.media
Oracle Q2 2026 earnings: AI growth vs debt risk - ig.com
Orix Metro launches Project NXT with Oracle NetSuite - Newsbytes.PH
Oracle 2Q26 earnings: AI growth vs debt risk - ig.com
Oracle EBS breach confirmed by Barts Health NHS - SC Media
Oracle (ORCL): Revisiting Valuation as AI Cloud Backlog, OpenAI Deal and New Coverage Drive Momentum - simplywall.st
Key facts: Oracle to report earnings; RPO rises 359% to $455 billion - TradingView
Dear Oracle Stock Fans, Mark Your Calendars for December 10 - Barchart.com
FOMC On Deck, Oracle Earnings, And Value Rotation Takes the Lead - Benzinga
Oracle: Low Enough Expectations For Q2 Upside (Rating Upgrade) (NYSE:ORCL) - Seeking Alpha
Digital Realty (DLR): Evaluating Valuation as It Expands AI-Optimized Data Centers and Oracle Connectivity in Singapore - Yahoo Finance
Oracle earnings have a lot riding on them, including crypto - Yahoo Finance
Should You Buy, Sell or Hold Oracle Stock Before Q2 Earnings? - The Globe and Mail
Top Stocks With Earnings This Week: GameStop, Broadcom, Oracle and More - Benzinga
Oracle’s 40% Correction: Valuation Reset Or Capex Warning? - Trefis
Oracle Turned $1,000 Into $5,726 Over a Decade but Recent Buyers Lost 37% - Yahoo Finance
Digi Power X taps former Oracle and VeriSign leader as CTO - Proactive financial news
Bernstein reiterates Oracle stock rating at Outperform with $364 target - Investing.com
Barclays Adjusts Price Target on Oracle to $330 From $400, Maintains Overweight Rating - marketscreener.com
Oracle Gets Mizuho Reaffirmation as Firm Maintains Outperform Despite Share Pullback - Yahoo! Finance Canada
ORACLE CORP : Gets a Buy rating from Barclays - marketscreener.com
NewsZero-Day Oracle Flaw Leads to Major Data Breach at University of Phoenix - teiss
What to watch out for from 'the AI Oracle' this week - TradingView
Mizuho reiterates Outperform rating on Oracle stock amid share pullback - Investing.com
ORACLE CORP : Buy rating from Jefferies - marketscreener.com
Citi lowers Oracle (ORCL) PT to $375 on valuation concerns, maintains buy rating expecting strong bookings - MSN
Citi Lowers Oracle (ORCL) PT to $375 on Valuation Concerns, Maintains Buy Rating Expecting Strong Bookings - Finviz
Ex-Employee Sues Washington Post Over Oracle EBS-Related Data Breach - Security Boulevard
Digital Realty Expands Connectivity to Oracle Cloud Infrastructure in Singapore with New FastConnect and Solution Center - Quiver Quantitative
Finanzdaten der Oracle Corp-Aktie (ORCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
1.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):